49 studies found for:    Open Studies | "Hair Diseases"
Show Display Options
Rank Status Study
21 Unknown  Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Condition: Alopecia
Intervention: Drug: AS101
22 Recruiting Pilot Study of a Novel IPL for Removal of Unwanted Fine Body Hair
Condition: Hypertrichosis
Intervention: Device: Prowave LX IPL
23 Recruiting Tofacitnib for the Treatment of Alopecia Areata and Variants
Conditions: Alopecia Areata (AA);   Alopecia Totalis (AT);   Alopecia Universalis (AU)
Intervention: Drug: Tofacitinib Administration
24 Not yet recruiting Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Conditions: Alopecia;   Breast Cancer
Interventions: Drug: bimatoprost ophthalmic solution;   Drug: placebo
25 Recruiting Safety and Efficacy of Nitric Oxide Gel in Promoting Hair Growth in Male Human Subjects With Androgenetic Alopecia
Condition: Alopecia Androgenica
Interventions: Other: Nitric Oxide (NO) Gel;   Other: Placebo gel
26 Recruiting Minoxidil Response Testing in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Drug: 5% minoxidil topical foam
27 Recruiting Treatment of Androgenetic Alopecia in Males and Females
Condition: Androgenetic Alopecia
Interventions: Device: TopHat 655 rejuvenation system;   Device: Laser and/or Light Hair Rejuvenation System
28 Unknown  Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection
Conditions: Impetigo;   Folliculitis;   Secondarily Infected Eczema;   Minor Soft Tissue Infections
Intervention: Drug: Retapamulin (Altabax)
29 Unknown  The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
30 Unknown  Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention:
31 Unknown  Efficacy and Safety Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Androgenetic Alopecia
Conditions: Objective (Goal);   Self-Assessment;   Adverse Effects
Interventions: Drug: 5% MInoxidil milky lotion;   Drug: 5% Minoxidil solution
32 Not yet recruiting Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
33 Recruiting Vytorin in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: vytorin
34 Recruiting Excimer Light for Alopecia Areata
Condition: Alopecia Areata
Intervention: Procedure: UVB excimer light
35 Unknown  Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Condition: Alopecia
Intervention: Drug: Clobetasol Propionate 0.05% Emollient Foam
36 Not yet recruiting Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia
Condition: Alopecia
Interventions: Drug: Dutasteride;   Drug: Placebo
37 Recruiting Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Conditions: Menkes Disease;   Occipital Horn Syndrome;   Unexplained Copper Deficiency
Intervention: Drug: Copper Histidine
38 Unknown  Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Condition: Alopecia
Interventions: Drug: 7% (w/v) Tempol alcohol-based gel (MTS-01);   Drug: alcohol-based gel
39 Recruiting Safety and Efficacy of Bimatoprost 0.03% Solution for the Treatment of Thinning Eyebrows
Condition: Hypotrichosis
Interventions: Drug: Track A;   Drug: Track B
40 Recruiting Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss
Condition: Androgenetic Alopecia
Interventions: Dietary Supplement: HCap Formula;   Dietary Supplement: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results
Indicates status has not been verified in more than two years